CDK9 inhibitors for haematological malignancy treatment
Drug Target Review,
A novel category of drugs, CDK9 inhibitors, emerges as potent agents capable of suppressing the transcription of these anti-apopt…
A novel category of drugs, CDK9 inhibitors, emerges as potent agents capable of suppressing the transcription of these anti-apopt…
These new findings evidence the necessity of more research in Gln metabolism to define the best therapeutic strategies for…
A promising new treatment for hematological malignancies August 11, 2023 Source:drugdu 21 A new research perspective was…
A new research perspective was published inOncotarget'sVolume 14on August 7, 2023, entitled, CDK9 INHIBITORS: a promising…